Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Genetic factors affecting blood lipoproteins: the candidate gene approach.
1988
Child abuse: Adolescent records vs. adult recall
1990 Standout
Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates.
1998
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
1992
Changes of lipolytic enzymes cluster with insulin resistance syndrome
1995
Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis
1992
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia
1993
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
The metabolic syndrome
2010 Standout
Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion
1994
Exercise Standards for Testing and Training
2013 Standout
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide Synthase
2008
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
1990
Metabolic origins and clinical significance of LDL heterogeneity
2002
Cellular Cholesterol Efflux Mediated by Cyclodextrins
1995 Standout
Chronic kidney disease
2011 Standout
Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins
1992
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Influence of mild to moderately elevated triglyceride’s on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels
1999
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 Standout
Adipokines in inflammation and metabolic disease
2011 Standout
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Genetic heterogeneity of lipoproteins in inbred strains of mice: Analysis by gel-permeation chromatography
1990
Thiazolidinediones and the liver in humans
2009
The metabolic syndrome
2005 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
COPII-coated vesicles: flexible enough for large cargo?
2005 StandoutNobel
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Diabetes and Atherosclerosis
2002 Standout
Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins
1999
Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy
1994
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance
1995
Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
2005
The Visceral Adiposity Syndrome in Japanese‐American Men
1994
Effects of fibrates on serum lipids and atherosclerosis
1988
Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels
1996
Mode of action of fibrates
1992
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Fibric acids: Effects on lipids and lipoprotein metabolism
1987
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B–containing lipoproteins
2008 StandoutNobel
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45
1993
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
1998 Standout
Effects of Diets Rich in Fermentable Carbohydrates on Plasma Lipoprotein Levels and on Lipoprotein Catabolism in Rats
1990
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Obesity and Heart Disease
1997
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
1992 StandoutScience
Plasma triglyceride and coronary heart disease.
1991
Genetic Models of Human Vascular Disease
1995 StandoutNobel
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
1992
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL
1999
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
2003 Standout
Total, LDL, and HDL Cholesterol Decrease With Age in Older Men and Women
1997
Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome
2002
Proatherogenic and Antiatherogenic Effects of Probucol and Phytosterols in Apolipoprotein E–Deficient Mice
1999
Pyripyropene A, an Acyl–Coenzyme A:Cholesterol Acyltransferase 2–Selective Inhibitor, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia
2011 StandoutNobel
Mechanisms and consequences of cellular cholesterol exchange and transfer
1987
Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction
1997
[1] Role of free radicals and catalytic metal ions in human disease: An overview
1990 Standout
Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.
1989
The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity1
2001
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
1993
2 Lipoproteins and atherosclerosis
1987
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions
2000 Standout
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
1988
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
1990
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 Standout
Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins.
1992
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
1996 StandoutScience
Description of two different patients with abetalipoproteinemia: synthesis of a normal-sized apolipoprotein B-48 in intestinal organ culture.
1990
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Differential Effects of Exercise on Serum Lipid and Lipoprotein Levels Seen With Changes in Body Weight
1985
Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1
1999
The Hyperlipidemia of the Nephrotic Syndrome
1985
The Metabolic Syndrome
2008 Standout
The Role of the Microsomal Triglygeride Transfer Protein in Abetalipoproteinemia
2000
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
1998 StandoutNobel
[1] Introduction to the plasma lipoproteins
1986
Effect of fish oil versus lard diets on the chemical and physical properties of low density lipoproteins of nonhuman primates.
1987
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis.
1992
High density lipoprotein metabolism.
1984
Low Expression of the Apolipoprotein B mRNA–Editing Transgene in Mice Reduces LDL Levels but Does Not Cause Liver Dysplasia or Tumors
1998 StandoutNobel
Works of Y Oschry being referenced
In vivo conversion of human HDL3 to HDL2 and apoE-rich HDL1 in the rat: effects of lipid transfer protein.
1987
Rat plasma lipoproteins: re-evaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity
1982
Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients
1987
Abnormal regulation of LDL receptor activity and abnormal cellular metabolism of hypertriglyceridaemic low density lipoprotein: normalization with bezafibrate therapy
1987
Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters.
1982
Preferential uptake of lipids by mycoplasma membranes from human plasma low-density lipoproteins
1982
Abnormal high density lipoproteins of abetalipoproteinemia: relevance to normal HDL metabolism
1982
Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.
1984
Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.
1985
Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases.
1986
Removal defect of very-low-density lipoproteins from diabetic rats
1984
Intravascular metabolism of the cholesteryl ester moiety of rat plasma lipoproteins.
1984
Plasma triglyceride determines structure-composition in low and high density lipoproteins.
1984
Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein?
1985
Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition.
1984